STOCK TITAN

T. Rowe Price files 13G on Elanco; sole voting 31,482,581

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

T. Rowe Price Investment Management, Inc. filed a Schedule 13G reporting beneficial ownership of 31,547,970 shares (6.4%) of Elanco Animal Health common stock as of 09/30/2025.

The filer reports sole voting power over 31,482,581 shares and sole dispositive power over 31,547,970 shares, with no shared voting or dispositive power. It certifies the holdings were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:11/14/2025
Elanco Animal Health

NYSE:ELAN

ELAN Rankings

ELAN Latest News

ELAN Latest SEC Filings

ELAN Stock Data

12.34B
491.25M
1.03%
109.82%
5.2%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
INDIANAPOLIS